Timothy C. Jenkins

Timothy C. Jenkins

Auto-generated profile, based on publicly available information

Timothy C. Jenkins

Division of Infectious Diseases, Department of Medicine, Denver Health , Denver, Colorado

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
TJTimothy C. Jenkins
Timothy C. Jenkins
CPConnie S. Price
Connie S. Price
ASAllison L. Sabel
Allison L. Sabel
PMPhilip S. Mehler
Philip S. Mehler
WBWilliam J. Burman
William J. Burman
Background. Staphylococcus aureus bacteremia causes considerable morbidity and mortality, and strategies to improve management and outcomes of this d

15 October 2010 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
TJTimothy C. Jenkins
Timothy C. Jenkins
ASAllison L. Sabel
Allison L. Sabel
ESEllen E. Sarcone
Ellen E. Sarcone
CPConnie S. Price
Connie S. Price
PMPhilip S. Mehler
Philip S. Mehler
WBWilliam J. Burman
William J. Burman
Background. Although complicated skin and soft-tissue infections (SSTIs) are among the most common infections requiring hospitalization, their clinic

27 June 2011 in Archives of internal medicine (1960)
Verified
Journal Article
Closed access
PDF file
TJTimothy C. Jenkins
Timothy C. Jenkins
BKBryan C. Knepper
Bryan C. Knepper
ASAllison L. Sabel
Allison L. Sabel
ESEllen E. Sarcone
Ellen E. Sarcone
JLJeremy A. Long
Jeremy A. Long
WBWilliam J. Burman
William J. Burman
Research from JAMA Internal Medicine — Decreased Antibiotic Utilization After Implementation of a Guideline for Inpatient Cellulitis and Cutaneous Abscess

1 March 2009 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
TJTimothy C. Jenkins
Timothy C. Jenkins
BMBruce D. McCollister
Bruce D. McCollister
RSRohini Sharma
Rohini Sharma
KMKim K. McFann
Kim K. McFann
NMNancy E. Madinger
Nancy E. Madinger
WBWilliam J. Burman
William J. Burman
Objective.: To describe the epidemiology of bloodstream infection caused by USA300 strains of methicillin-resistantStaphylococcus aureus(MRSA), which are traditionally associated with cases of community-acquired infection, in the healthcare setting.Design.: Retrospective cohort study.Setting.: Three academically affiliated hospitals in Denver, Colorado.Methods.: Review of cases of S.aureusbloodstream infection during the period from 2003 through 2007. Polymerase chain reaction was used to identify MRSA USA300 isolates.Results.: A total of 330 cases of MRSA bloodstream infection occurred during the study period, of which 286 (87%) were healthcare-associated. The rates of methicillin resistance among theS. aureusisolates recovered did not vary during the study period and were similar among the 3 hospitals. However, the percentages of cases of healthcare-associated MRSA bloodstream infection due to USA300 strains varied substantially among the 3 hospitals: 62%, 19%, and 36% (P< .001) for community-onset cases and 33%, 3%, and 33% (P= .005) for hospital-onset cases, in hospitals A, B, and C, respectively. In addition, the number of cases of healthcare-associated MRSA bloodstream infection caused by USA300 strains increased during the study period at 2 of the 3 hospitals. At each hospital, USA300 strains were most common among cases of community-associated infection and were least common among cases of hospital-onset infection. Admission to hospital A (a safety-net hospital), injection drug use, and human immunodeficiency virus infection were independent risk factors for healthcare-associated MRSA bloodstream infection due to USA300 strains.Conclusions.: The prevalence of USA300 strains among cases of healthcare-associated MRSA bloodstream infection varied dramatically among geographically clustered hospitals. USA300 strains are replacing traditional healthcare-related strains of MRSA in some healthcare settings. Our data suggest that the prevalence of USA300 strains in the community is the dominant factor affecting the prevalence of this strain type in the healthcare setting.

1 December 2013 in The American Journal of Medicine
Verified
Journal Article
Closed access
HHHermione J. Hurley
Hermione J. Hurley
BKBryan C. Knepper
Bryan C. Knepper
CPConnie S. Price
Connie S. Price
PMPhilip S. Mehler
Philip S. Mehler
WBWilliam J. Burman
William J. Burman
TJTimothy C. Jenkins
Timothy C. Jenkins

1 April 2013 in The American Journal of Medicine
Verified
Journal Article
Closed access
TJTimothy C. Jenkins
Timothy C. Jenkins
AIAmy Irwin
Amy Irwin
LCLetoynia Coombs
Letoynia Coombs
LDLauren DeAlleaume
Lauren DeAlleaume
SRStephen E. Ross
Stephen E. Ross
CPConnie S. Price
Connie S. Price